[SciVision Biotech Inc.] 2026 Q1 EPS 0.29
Key facts
- [SciVision Biotech Inc.] 2026 Q1 EPS 0.29
- SciVision Biotech Inc. reported its Q1 2026 financial results with an EPS of 0.29, revenue of 205 million NTD, and a net profit of 22 million NTD.
- Source: PR Times
- Date: March 1, 2026
Direct answer
SciVision Biotech Inc. reported its Q1 2026 financial results with an EPS of 0.29, revenue of 205 million NTD, and a net profit of 22 million NTD.
- Citation
- [SciVision Biotech Inc.] 2026 Q1 EPS 0.29 (March 1, 2026), PR Times
- Source
- PR Times
- Date
- March 1, 2026
SciVision Biotech Inc. reported its Q1 2026 financial results with an EPS of 0.29, revenue of 205 million NTD, and a net profit of 22 million NTD.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: May 15, 2026 at 08:01 (1799h 1m after Published)
- 🤖 AI Analyzed: May 15, 2026 at 19:52 (11h 51m after Collected)
Company Code: 1786
Company Name: SciVision Biotech Inc.
Industry: Biotechnology and Medical Care
Year/Quarter: 2026 Q1
Basic Earnings Per Share (EPS): 0.29
Operating Revenue: 0.205 billion
Net Income After Tax: 0.022 billion
Company Name: SciVision Biotech Inc.
Industry: Biotechnology and Medical Care
Year/Quarter: 2026 Q1
Basic Earnings Per Share (EPS): 0.29
Operating Revenue: 0.205 billion
Net Income After Tax: 0.022 billion
FAQ
What are the key facts in this article?
SciVision Biotech Inc. reported its Q1 2026 financial results with an EPS of 0.29, revenue of 205 million NTD, and a net profit of 22 million NTD.
What is the direct answer?
SciVision Biotech Inc. reported its Q1 2026 financial results with an EPS of 0.29, revenue of 205 million NTD, and a net profit of 22 million NTD.
What is the source and date?
PR Times: https://openapi.twse.com.tw/financial/twse-fin-1786-2026Q1 | March 1, 2026